<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001143313</cik>
        <entityName>NYSE AMERICAN LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001528557</cik>
        <entityName>Corindus Vascular Robotics, Inc.</entityName>
        <fileNumber>001-37406</fileNumber>
        <address>
            <street1>309 Waverley Oaks Road, Suite 105</street1>
            <city>Waltham</city>
            <stateOrCountryCode>MA</stateOrCountryCode>
            <stateOrCountry>MASSACHUSETTS</stateOrCountry>
            <zipCode>02452</zipCode>
        </address>
        <telephoneNumber>(508) 653-3335</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Common Stock par value $0.0001 per share</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(3)</ruleProvision>

    <signatureData>
        <signatureName>Christopher Rances</signatureName>
        <signatureTitle>Senior Analyst</signatureTitle>
        <signatureDate>2019-10-29</signatureDate>
    </signatureData>
</notificationOfRemoval>
